These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7817555)

  • 21. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
    Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
    Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of monoclonal antibodies for the immuno-imaging of cancers].
    Endo K; Oriuchi N; Takenoshita S
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):170-5. PubMed ID: 8311487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoscintigraphy of colorectal cancer with an antibody to epithelial membrane antigen (EMA).
    Yiu CY; Baker LA; Davidson BR; Ward M; Roberts K; Clarke G; Ward C; Westwood J; Boulos PB; Clark CG
    Dis Colon Rectum; 1990 Feb; 33(2):122-6. PubMed ID: 2404713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody imaging in colon cancer: a transition from basic science to clinical application.
    Kim SL; Goldschmid S
    Am J Gastroenterol; 1994 Oct; 89(10):1910-2. PubMed ID: 7942701
    [No Abstract]   [Full Text] [Related]  

  • 25. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
    Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
    Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmune localization of occult carcinoma.
    Duda RB; Zimmer AM; Rosen ST; Gilyon KA; Webber D; Spies S; Spies W; Merchant B
    Arch Surg; 1990 Jul; 125(7):866-70. PubMed ID: 2369311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer patients benefit from monoclonal imaging.
    Neal CE
    Diagn Imaging (San Franc); 1993 Jun; 15(6):92-7. PubMed ID: 10148791
    [No Abstract]   [Full Text] [Related]  

  • 28. Perioperative radioimmunolocalization of colorectal cancer by radiolabeled monoclonal antibodies.
    Badellino F; Percivale P; Meszaros P; Gipponi M; Bartolomeo S; Nicolo G; Spina B; Schenone F; Bertoglio S
    J Surg Oncol Suppl; 1991; 2():86-91. PubMed ID: 1892537
    [No Abstract]   [Full Text] [Related]  

  • 29. [Radioimmunoscintigraphy with monoclonal antibodies in recurrences and metastases of colorectal tumors].
    Roveda L
    Medicina (Firenze); 1990; 10(2):160-1. PubMed ID: 2273952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients.
    Jusko WJ; Kung LP; Schmelter RF
    Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
    Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
    An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
    Vuillez JP; Peltier P; Mayer JC; Dubois F; Chetanneau A; Fumoleau P; Bertrand A; Chatal JF
    J Nucl Med; 1991 Feb; 32(2):221-7. PubMed ID: 1992023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
    Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
    Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal antibodies as tumoritropic radiopharmaceutical preparations for immunolocalization of malignant neoplasms].
    Tkacheva GA
    Med Radiol (Mosk); 1991; 36(5):42-9. PubMed ID: 2034108
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunoscintigraphy with monoclonal antibody Tc99m BW 431/26 in the diagnosis of colorectal carcinoma].
    Muxí A; Bassa P; Moragas M; Fernández R; Pons F; Setoaín J
    Med Clin (Barc); 1991 Mar; 96(8):287-91. PubMed ID: 2041400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volume rendering and bicolour scale in double isotope studies: application to immunoscintigraphy and bone landmarking.
    Loboguerrero A; Pérault C; Liehn JC
    Eur J Nucl Med; 1992; 19(3):201-4. PubMed ID: 1572385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
    Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: current status and future perspectives.
    Nabi HA; Doerr RJ
    Am J Surg; 1992 Apr; 163(4):448-56. PubMed ID: 1558288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early results of the monoclonal antibody OVTL3 in specific detection of ovarian cancer.
    Epenetos AA; Lavender JP; Kenemans P; Poels L
    J Clin Oncol; 1987 Jan; 5(1):160. PubMed ID: 3806157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.